Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 11

M&A

Altamont Puts Part of Douglas Back in Play

By Tom Terrarosa
|
Published: August 8th, 2022
After shelving a process for all of Douglas Products in late 2021, Evercore is continuing its mandate by launching a process for the sewer services portion of the business, Duke's Root Control, The Deal has learned.
M&A

Equistone Taps Evercore to Shop United Initiators

By Tom Terrarosa
|
Published: August 8th, 2022
The $60 million-in-Ebitda specialty chemicals company is expected to attract European private equity firms, along with some strategics, The Deal has learned.
Private Equity

Exit Ramp: Epsilyte's Rapid Growth Builds Following

By Tom Terrarosa
|
Published: July 6th, 2022
The Balmoral-backed foam producer has gone from single- to triple-digit Ebitda practically overnight, leaving bankers to jostle early over who may one day earn the sell-side business.
M&A

Crestview Doubles Money in ICM Sale to CAA

By Chris Nolter
|
Published: July 5th, 2022
The deal, which closed June 28, clocked in at just under $800 million and netted the seller more than two times its initial investment, The Deal has learned.
Private Equity

Exit Ramp: Zenith May Be Next to Block in Warburg Oil Pruning

By Tom Terrarosa
|
Published: June 9th, 2022
After failing to raise another energy-dedicated fund in 2020, the firm appears to be making good on its promise to transition away from traditional oil investments, where it has invested for 30 years.
Private Equity

Excellere Looks to Exit Ag Chems Maker SePro

By Tom Terrarosa
|
Published: June 9th, 2022
The private equity firm has engaged Raymond James and Piper Sandler to market its stake in the Indiana-based chemicals company with around $40 million of Ebitda.
 
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
customerservice@thedeal.com
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act